Literature DB >> 17726743

Preoperative localization and minimally invasive management of primary hyperparathyroidism concomitant with thyroid disease.

Yi-xiong Zheng1, Shao-ming Xu, Ping Wang, Li Chen.   

Abstract

The coexistence of thyroid diseases with primary hyperparathyroidism (PHPT) can present a challenge in the clinical diagnosis and management for these patients. This study aims to determine the frequency of coexisting thyroid gland lesions in a consecutive series patients with PHPT, and to analyze the clinical features, diagnosis and treatment of these patients. Twenty-two cases of a total of 52 PHPT patients who had synchronous thyroid and parathyroid pathology were surgically managed in this study. Thirteen patients had ipsilateral thyroid nodules, and 9 patients had thyroid nodules in contralateral or bilateral side. Seven patients underwent direct parathyroidectomy and hemithyroidectomy via a mini-incision (about 3 cm), while other 15 procedures were converted to Kocher incision. Seventeen nodular goiter (32.7%), 2 thyroiditis (3.8%), 2 thyroid adenoma (3.8%) and 1 thyroid carcinoma (1.9%) coexisting with parathyroid adenoma were pathologically diagnosed. The sensitivity of preoperative ultrasonography (US) and methoxy-isobutyl-isonitrile (MIBI) scintigraphy for parathyroid lesions was 63.6% and 85.7%; and the overall positive predictive values for MIBI and US were 100% and 95.5% respectively. A high incidence of thyroid diseases that coexisted with PHPT in literatures was briefly reviewed. Our study illustrated the need for clinical awareness of concomitant PHPT and thyroid disease. A combination of US, computed tomography (CT) and MIBI scintigraphy would be recommended for preoperative localization of enlarged parathyroid adenoma and for evaluation of thyroid lesions. Synchronous treatment of associated thyroid abnormalities is desirable, and open minimally invasive surgical approach with additional resection of isolated ipsilateral thyroid nodules is possible in some of these patients.

Entities:  

Mesh:

Year:  2007        PMID: 17726743      PMCID: PMC1963428          DOI: 10.1631/jzus.2007.B0626

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  17 in total

1.  Thyroid pathology associated with primary hyperparathyroidism.

Authors:  S Sidhu; P Campbell
Journal:  Aust N Z J Surg       Date:  2000-04

2.  Impact of localization studies on feasibility of minimally invasive parathyroidectomy in an endemic goiter region.

Authors:  Gerhard Prager; Christian Czerny; Sedan Ofluoglu; Amir Kurtaran; Christian Passler; Klaus Kaczirek; Christian Scheuba; Bruno Niederle
Journal:  J Am Coll Surg       Date:  2003-04       Impact factor: 6.113

3.  Prevalence of primary hyperparathyroidism in 13387 patients with thyroid diseases, newly diagnosed by screening of serum calcium.

Authors:  B Wagner; S Begic-Karup; W Raber; B Schneider; W Waldhäusl; H Vierhapper
Journal:  Exp Clin Endocrinol Diabetes       Date:  1999       Impact factor: 2.949

4.  Can localization studies be used to direct focused parathyroid operations?

Authors:  C Arici; W K Cheah; P H Ituarte; E Morita; T C Lynch; A E Siperstein; Q Y Duh; O H Clark
Journal:  Surgery       Date:  2001-06       Impact factor: 3.982

5.  Is preoperative investigation of the thyroid justified in patients undergoing parathyroidectomy for hyperparathyroidism?

Authors:  David J Bentrem; Peter Angelos; Mark S Talamonti; Ritu Nayar
Journal:  Thyroid       Date:  2002-12       Impact factor: 6.568

Review 6.  Surgical approaches to primary hyperparathyroidism.

Authors:  M S Eigelberger; O H Clark
Journal:  Endocrinol Metab Clin North Am       Date:  2000-09       Impact factor: 4.741

7.  Concomitant Graves' disease and primary hyperparathyroidism: the first case report in mainland of China and literature review.

Authors:  Haipeng Xiao; Binjie Yu; Shenming Wang; Guorui Chen
Journal:  Chin Med J (Engl)       Date:  2002-06       Impact factor: 2.628

8.  [Minimal invasive surgery for pHPT--which patients will profit?].

Authors:  L Schiffmann; B Mann; H Hotz; H J Buhr
Journal:  Zentralbl Chir       Date:  2003-07       Impact factor: 0.942

9.  [Hyperparathyroidism associated with thyroid disease. Retrospective study of 15 patients treated in 11 years].

Authors:  Vicente Pino Rivero; Luis Marqués Rebollo; Alfonso Ambel Albarrán; Gabriel Trinidad Ruíz; Guillerma Pardo Romero; Antonio Blasco Huelva
Journal:  An Otorrinolaringol Ibero Am       Date:  2003

10.  Simultaneous primary hyperparathyroidism and nodular thyroid disease.

Authors:  R A Prinz; A L Barbato; S S Braithwaite; M H Brooks; M A Emanuele; D L Gordon; A M Lawrence; E Paloyan
Journal:  Surgery       Date:  1982-09       Impact factor: 3.982

View more
  12 in total

1.  Can ARFI elastography be used to differentiate parathyroid from thyroid lesions?

Authors:  A Chandramohan; M Therese; D Abhraham; T V Paul; P Jacob Mazhuvanchary
Journal:  J Endocrinol Invest       Date:  2017-05-31       Impact factor: 4.256

2.  Co-existent thyroid disease in patients treated for primary hyperparathyroidism: implications for clinical management.

Authors:  S Ryan; D Courtney; C Timon
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-15       Impact factor: 2.503

3.  Parathyroid incidentalomas detected during thyroid ultrasonography and effect of chronic thyroiditis on false positive parathyroid lesions.

Authors:  Didem Ozdemir; Dilek Arpaci; Rifki Ucler; Neslihan Cuhaci; Reyhan Ersoy; Bekir Cakir
Journal:  Endocrine       Date:  2012-05-23       Impact factor: 3.633

4.  Surgical management of primary hyperparathyroidism.

Authors:  Stephen Ryan; Danielle Courtney; Julia Moriariu; Conrad Timon
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-10-16       Impact factor: 2.503

5.  Incidence of concomitant hyperparathyroidism in patients with thyroid disease requiring surgery.

Authors:  Sara E Murray; Rebecca S Sippel; Herbert Chen
Journal:  J Surg Res       Date:  2012-03-30       Impact factor: 2.192

6.  Concomitant thyroid disease and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomy.

Authors:  Marie-Christine Wright; Kelly Jensen; Hossam Mohamed; Carolyn Drake; Khuzema Mohsin; Dominique Monlezun; Nuha Alsaleh; Emad Kandil
Journal:  Gland Surg       Date:  2017-08

Review 7.  Minimally invasive parathyroidectomy: benefits and requirements of localization, diagnosis, and intraoperative PTH monitoring. long-term results.

Authors:  Douglas L Fraker; Hasly Harsono; Robert Lewis
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

8.  Surgical treatment of concomitant thyroid and parathyroid disorders: analysis of 4882 cases.

Authors:  Milan D Jovanovic; Vladan R Zivaljevic; Aleksandar D Diklic; Branislav R Rovcanin; Goran V Zoric; Ivan R Paunovic
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-09-12       Impact factor: 2.503

9.  Institutional experience of PTH evaluation on fine-needle washing after aspiration biopsy to locate hyperfunctioning parathyroid tissue.

Authors:  Massimo Giusti; Mara Dolcino; Lara Vera; Carla Ghiara; Francesca Massaro; Laura Fazzuoli; Diego Ferone; Michele Mussap; Francesco Minuto
Journal:  J Zhejiang Univ Sci B       Date:  2009-05       Impact factor: 3.066

10.  ARE THYROID NODULES AN OBSTACLE TO MINIMAL INVASIVE PARATHYROID SURGERY? A SINGLE-CENTER STUDY FROM AN ENDEMIC GOITER REGION.

Authors:  S Özden; B Saylam; G Daglar; Y N Yuksek; M Tez
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Oct-Dec       Impact factor: 0.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.